Mauna Kea Technologies

maunakeatech.com

Mauna Kea
Mauna Kea Technologies is a global medical device company that manufactures and sells Cellvizio®, the real-time in vivo cellular imaging platform.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

XRHEALTH LAUNCHES FIRST VIRTUAL REALITY TELEHEALTH CLINIC

HIT Consultant | February 12, 2020

news image

XRHealth, formerly known as VRHealth, the leader in extended reality and therapeutic applications, today announced the first virtual reality telehealth clinics that will provide VR therapy to patients. VR telehealth clinicians providing care are currently certified in Massachusetts, Connecticut, Florida, Michigan, Washington D.C., Delaware, California, New York, and North Carolina and will be expanding their presence in additional states in the coming months. The XRHealth telehealth servic...

Read More

HEALTH TECHNOLOGY

ATOS AND HUMA FORM A FIVE-YEAR PARTNERSHIP TO IMPROVE HEALTHCARE AND RESEARCH WITH INNOVATIVE REMOTE MONITORING TECHNOLOGIES

Atos | June 07, 2021

news image

Atos and Huma, a digital health innovator, has announced a five-year strategic global partnership to move healthcare and clinical trials out of hospitals and people's homes. The partnership will center on Huma's modular platform, which can power digital "home hospitals" nationally and assist pharmaceutical and research industries in running sophisticated worldwide, decentralized clinical tria...

Read More

BIO PRODUCTS LABORATORY ANNOUNCES LAUNCH OF ALBUMINEX® 5% AND ALBUMINEX® 25% WITH SUPPLY IMMEDIATELY AVAILABLE IN THE UNITED STATES

Bio Products Laboratory | May 29, 2020

news image

Bio Products Laboratory (BPL), a leading manufacturer of plasma-derived protein therapies with US headquarters in Durham, North Carolina, and worldwide headquarters and manufacturing facilities in Elstree, UK, today announced the US launch of ALBUMINEX 5% (human albumin) solution for injection and ALBUMINEX 25% (human albumin) solution for injection, with supply immediately available. ALBUMINEX 5% and ALBUMINEX 25% are approved by the US Food and Drug Administration for the treatment of hypovole...

Read More

MICROSOFT COMMITS $40M TO AI FOR HEALTH INITIATIVE

MedCity News | January 30, 2020

news image

Microsoft unveiled the details of its latest effort as part of its $165 million AI for Good program. The company plans to spend $40 million over the next five years to support research and public health efforts under its new AI for Health initiative. Microsoft shared its plans on Wednesday, which include giving nonprofits and academic researchers access to the company’s AI tools, cloud computing resources, and collaboration with the company’s data scientists. Certain projects will al...

Read More
news image

XRHEALTH LAUNCHES FIRST VIRTUAL REALITY TELEHEALTH CLINIC

HIT Consultant | February 12, 2020

XRHealth, formerly known as VRHealth, the leader in extended reality and therapeutic applications, today announced the first virtual reality telehealth clinics that will provide VR therapy to patients. VR telehealth clinicians providing care are currently certified in Massachusetts, Connecticut, Florida, Michigan, Washington D.C., Delaware, California, New York, and North Carolina and will be expanding their presence in additional states in the coming months. The XRHealth telehealth servic...

Read More
news image

HEALTH TECHNOLOGY

ATOS AND HUMA FORM A FIVE-YEAR PARTNERSHIP TO IMPROVE HEALTHCARE AND RESEARCH WITH INNOVATIVE REMOTE MONITORING TECHNOLOGIES

Atos | June 07, 2021

Atos and Huma, a digital health innovator, has announced a five-year strategic global partnership to move healthcare and clinical trials out of hospitals and people's homes. The partnership will center on Huma's modular platform, which can power digital "home hospitals" nationally and assist pharmaceutical and research industries in running sophisticated worldwide, decentralized clinical tria...

Read More
news image

BIO PRODUCTS LABORATORY ANNOUNCES LAUNCH OF ALBUMINEX® 5% AND ALBUMINEX® 25% WITH SUPPLY IMMEDIATELY AVAILABLE IN THE UNITED STATES

Bio Products Laboratory | May 29, 2020

Bio Products Laboratory (BPL), a leading manufacturer of plasma-derived protein therapies with US headquarters in Durham, North Carolina, and worldwide headquarters and manufacturing facilities in Elstree, UK, today announced the US launch of ALBUMINEX 5% (human albumin) solution for injection and ALBUMINEX 25% (human albumin) solution for injection, with supply immediately available. ALBUMINEX 5% and ALBUMINEX 25% are approved by the US Food and Drug Administration for the treatment of hypovole...

Read More
news image

MICROSOFT COMMITS $40M TO AI FOR HEALTH INITIATIVE

MedCity News | January 30, 2020

Microsoft unveiled the details of its latest effort as part of its $165 million AI for Good program. The company plans to spend $40 million over the next five years to support research and public health efforts under its new AI for Health initiative. Microsoft shared its plans on Wednesday, which include giving nonprofits and academic researchers access to the company’s AI tools, cloud computing resources, and collaboration with the company’s data scientists. Certain projects will al...

Read More